Hot Investor Mandate: Hong Kong PE Firm Seeks to Invest Up to $10 M in Clinically Validated Medical Device and Diagnostics Products with China Angle

12 Jul

A PE firm that is headquartered in Hong Kong with additional offices throughout China currently manages over US$4 billion in assets and invests across several industry sectors including healthcare. The firm is interested in pre-growth and growth stage companies. Typical investment size ranges from US$5-10 million in Series A rounds. The firm seeks to lead but is open to syndicating with co-investors. The firm is now looking for opportunities in China, the US, and Canada.

Within healthcare, the firm focuses on medical devices and diagnostic technologies that have a China angle. The firm prefers products that have achieved clinical validation with proven advantages. The firm is also interested in clinical-stage biopharmaceutical opportunities as well as health information technology. The firm is opportunistic in terms of indication areas but is less interested in orphan diseases.

The firm is looking for experienced management teams with track record of success. The firm typically requests board representation in its portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: Newly Established VC Fund Invests in Innovative Digital Health and Medtech/Diagnostics Technologies with Software Components

12 Jul

A new venture fund started investing in pre-seed, seed and Series A rounds. The firm’s main investment areas are in companies that advance and improve human health through novel models of care delivery and in companies that are at the cutting-edge of frontier technology, such as neurotech, brain/machine interfaces, genomics and AI. The firm will consider digital health companies as well as diagnostics and medical device companies, as long as they have a software component. The firm will only invest in companies with disruptive technology, not incremental innovations. The firm will invest between $.1-1.5M in the initial investment, with the possibility of participating in following rounds. The firm is willing to lead or co-invest, has made 7 investments to date and is looking to invest in 4-6 companies a year.

The firm will consider digital health companies that are focused on improving patient care. Ideally, companies will already have a pilot with some outcomes-based data indicating traction. The firm is also interested in medical device companies, but will only invest if there is a significant software and/or radical innovation component. The firm will also consider diagnostics, such as genomics-based technologies, but not in vitro diagnostics. The firm will not invest in traditional therapeutics (i.e. small molecule or biologics) companies but will consider software-as-medicine and bioelectronic medicine.

Due to the firm’s preference for cutting-edge technology, the firm prefers that there be at least one technical expert in the company leadership. If acting as a lead investor, the firm will take a board or board observer seat. The firm prefers to be an active investor, providing multi-faceted support to portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Be Part of the Healthcare Innovation Boom: Join the First Coast Innovator’s Gathering

10 Jul

By Ashley Durrer, Marketing Manager, LSN

The first half of 2018 has brought to the surface many debated topics not only for the United States but also the world—universal healthcare, innovation, and leadership. This year, headlines continue to arise almost daily detailing reforms to the healthcare system, while other countries continue to make advances in their universal healthcare programs. One of the biggest corporations in the world, Amazon, is accelerating their involvement in the healthcare industry with big-name partnerships, leadership appointments, and strategic acquisitions. They’ve also recently purchased office space in Boston, MA, one of the biggest life science hubs in the world—where Life Science Nation (LSN) began its focus on helping early-stage life science companies seeking capital.

The urgency in healthcare.

Life Science Nation was founded with the intention to move life science innovation forward for a real impact on the global development of healthcare, which has only become more urgent. Throughout LSN’s experience supporting life science companies, lack of access to capital is holding back the advancement of many life science companies. LSN dedicates itself to helping early-stage companies navigate the funding ‘Valley of Death’, which is why LSN created a new three-day event called RESI Healthtech Week. Today, LSN will discuss the benefit of attending Day 1, the First Coast Innovator’s Gathering, for tech hubs across the northeast with technologies or companies looking to change the future of healthcare.

What is the First Coast?

The First Coast, as LSN has deemed it, is the location identified as the premier hub for life science innovation, similar to how Silicon Valley is viewed as the premier (and original) tech hub. Over the years the First, Second, and Third Coast have been identified as hubs across the country made up of different states including Houston and New York City. All have been vying to be central locations for massive innovation in the life sciences. However, Life Science Nation takes the First Coast to include the entire northeast corridor, from DC to MA, including all the premier universities and research institutions in the region.

RESI Healthtech Week’s new First Coast Innovator’s Gathering is focused on expanding the traditional Redefining Early Stage Investments (RESI) Conference to include more nascent technologies and companies in the life science space. By bringing together innovators from the entire northeast corridor with global investors and strategic partners, LSN promotes a one-of-a-kind opportunity for the advancement of healthcare innovation.

Who are the best-fit attendees?

Day 1 will feature the next generation of healthcare innovation and their earliest stage companies from the northeast region: DC, MD, PA, NJ, NY, RI, CT, and MA—now known as First Coast, who are invited to participate in a day of partnering and networking.

Qualifying First Coast Day 1 registrants are the northeast corridor incubators, accelerators, tech transfer offices, university translation initiatives, hospitals, research labs and their constituents as well as the investors and partners that seek them.

Ideal candidates include those seeing funding anywhere from $15k to $2M from grants, seed, and angel funding.

Affordability

LSN created an affordable registration price that will facilitate more startups attending the three-day event. Tickets start at only $500 for tech hubs (includes two tickets) and $300 for each additional constituent member. The pricing structure and benefits are presented in the chart below.

first coast innovator's gathering

Showcase Your Technologies.

The conference will include ample opportunities for you to represent and showcase your technologies to global investors and strategic partners. This includes exhibiting, online features and placements, as well as a competition for a spot to pitch investors during the First Coast Innovation Challenge.

The exhibit hall has limited space for one exhibit table per tech hub (as space allows). Each organization can have up to 5 poster boards for their table to showcase their tech hub members and constituents.

In addition, all tech hubs will be featured in the RESI Healthtech Week Program Guide. Their technologies represented by their constituents and tech hub members will be featured on the newsletter and website with a datasheet.

All qualifying First Coast registrants are eligible to apply for the First Coast Innovation Challenge where the top 5 finalists will give 10-minute pitches to an elite panel of investor judges from 3:00-5:00 during the First Coast Innovator’s Gathering. This will be a rewarding opportunity to pitch your technologies and receive valuable feedback.

Access to global investors.

LSN’s network of early-stage global investors will be able to see all the key players in one place and learn about the innovative technologies coming out of the First Coast.

 A day of partnering and networking.

Day 1 of the RESI Healthtech Week will feature the First Coast Innovator’s Gathering; partnering and networking opportunities, just like it’s traditional RESI.

The RESI Partnering Platform helps you find nontraditional partners from the newest sources of capital, including family offices, foundations, academic institutions, and philanthropic organizations that will be a fit for your technology and stage of development. Attendees can schedule up to 16 meetings using the Partnering Platform. It will open one month before the conference, so companies, global investors, and strategic partners can request and book meetings in advance. Some key highlights of the Partnering Platform include:

  • Review profiles of other RESI Conference participants.
  • Schedule one-on-one and/or group meetings.
  • Build your customized RESI Conference schedule, from panels to presentations to partnering meetings.
  • The system will be available one month before and one month after the conference for ease of use.
  • Launches August 6th for RESI Healthtech Week (September 5-6th) partnering.

In addition to the Partnering Platform, attendees can also participate in ad hoc meetings at exhibit tables and poster boards throughout the day.

Venue Information

The First Coast Innovator’s Gathering will take place at the Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA 02116, on September 5th, 2018 followed by the traditional Redefining Early Stage Investments Conference on September 6th, and the Entrepreneur’s Academy Workshop Series on September 7th.

Registration starts at 7 AM. Exhibit halls and meetings are available from 8 AM to 5 PM.

In conclusion…

Life Science Nation will continue to connect early-stage companies with global investors and strategic partners through RESI Conferences and first-in-class data platforms, in the hope that downstream we can help bring treatments to the patients that need them. As the landscape for healthcare and healthcare policy changes, so too will LSN in order to meet the needs of the early-stage players.

We hope to see you in September. Sign up today.

%d bloggers like this: